透過您的圖書館登入
IP:18.219.112.111
  • 期刊

The Mechanism of Mitochondria-Mediated Pathway in the Apoptosis of Platelets in Immune-Induced Bone Marrow Failure

本篇文章尚未正式出版,請點選「加入追蹤」跟進後續出版資訊!

摘要


Excessive platelet apoptosis is one of the pathogenic causes of immune-induced bone marrow failure (BMF). The aim of the present study was to explore the role of mitochondria-mediated pathway in the apoptosis of platelets in immune-induced BMF. An immune-induced BMF model was established in mice, which were randomly divided into three groups: normal control (CTL) group, BMF group and cyclosporine (CSA) group (n = 10 in each group). Mice were given 0.027 g/kg CSA daily in the CSA group. Platelet count (PLT), mitochondrial transmembrane potential (ΔΨm), cytochrome C (CytC), phosphatidylserine (PS), calcium ion (Ca^(2+)) and expression of proteins of the mitochondrial apoptotic pathway, including Bak, Bax, caspase-3, caspase-8 and caspase-9, was examined and compared. Compared with the CTL group, the BMF group had significantly a lower level of PLC and ΔΨm, but higher levels of CytC, PS, Ca^(2+) and higher expression levels of Bak, Bax, cleaved caspase-9 and cleaved caspase-3 (P < 0.05). CSA restored the above changes in the BMF model (P < 0.05). Further studies showed that intravenous injection of the caspase-9 inhibitor Z-LE(OMe)HD(OMe)-fluoromethylketone (FMK) into the mice could significantly inhibit apoptosis of the platelets and the effect of CSA treatment when compared to the BMF group, and exerted a better protective effect from apoptosis if the caspase-9 inhibitor was combined with the CSA treatment. These results revealed that platelet apoptosis may play an important role in the reduction of platelet of immune-induced BMF probably through the mitochondrial pathway.

參考文獻


Brown, S.B.,Clarke, M.C.,Magowan, L.,Sanderson, H.,Savill, J.(2000).Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program.J. Biol. Chem..275,5987-5996.
Chen, J.,Desierto, M.J.,Feng, X.,Biancotto, A.,Young, N.S.(2015).Immune-mediated bone marrow failure in C57BL/6 mice.Exp. Hematol..43,256-267.
Desborough, M.,Hadjinicolaou, A.V.,Chaimani, A.,Trivella, M.,Vyas, P.,Doree, C.,Hopewell, S.,Stanworth, S.J.,Estcourt, L.J.(2016).Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.Cochrane Database Syst. Rev..10,CD012055.
Jacobson, M.D.,Burne, J.F.,Raff, M.C.(1994).Programmed cell death and Bcl-2 protection in the absence of a nucleus.EMBO J..13,1899-1910.
Jagadish, S.,Rajeev, N.,NaveenKumar, S.K.,Sharath Kumar, K.S.,Paul, M.,Hegde, M.,Basappa, Sadashiva, M.P.,Girish, K.S.,Rangappa, K.S.(2016).Platelet protective efficacy of 3,4,5 trisubstituted isoxazole analogue by inhibiting ROS-mediated apoptosis and platelet aggregation.Mol. Cell. Biochem..414,137-151.

延伸閱讀